Erratum to: treatment with bexarotene, a compound that increases apolipoprotein-E, provides no cognitive benefit in mutant APP/PS1 mice

LaClair, Katherine D; Manaye, Kebreten F; Lee, Dexter L; Allard, Joanne S; Savonenko, Alena V; Troncoso, Juan C; Wong, Philip C

doi:10.1186/1750-1326-8-26

Article metrics
Last updated: Thu, 25 Apr 2024 12:43:47 Z

Erratum to: treatment with bexarotene, a compound that increases apolipoprotein-E, provides no cognitive benefit in mutant APP/PS1 mice

Access & Citations

1694

Article Accesses
2

Web of Science
1

CrossRef

Citation counts are provided from Web of Science and CrossRef. The counts may vary by service, and are reliant on the availability of their data. Counts will update daily once available.